Mentor/s
Dr. Mark Jareb and Dr. Barbara Pierce
Participation Type
Poster
Abstract
There are many different opposing studies about respiratory distress and how it affects premature infants as well as adults. The main focus is on how infants can be treated of acute respiratory distress syndrome or ARDS, which is more common when they are born prematurely. This analytical review is designed to capture all the past and present data in order to present both sides of controversy in the different treatments to treat respiratory distress in premature infants. The data finds that inhaled nitric oxide (iNO) is one of the main treatments for respiratory distress and has had a lot of controversy over the years. Most of the research points to the usefulness of iNO in different doses, although it is controversial as to the right dose amount. There are also a few other treatment possibilities that still need further research. iNO is useful as a treatment, and to hold as a temporary treatment before other treatments can be administered. However, it still has different risks involved especially when dealing with infants.
College and Major available
Biology
Location
Panel C: UC 107
Start Day/Time
4-21-2017 2:00 PM
End Day/Time
4-21-2017 3:15 PM
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.
Treatment for Respiratory Distress in Premature Infants
Panel C: UC 107
There are many different opposing studies about respiratory distress and how it affects premature infants as well as adults. The main focus is on how infants can be treated of acute respiratory distress syndrome or ARDS, which is more common when they are born prematurely. This analytical review is designed to capture all the past and present data in order to present both sides of controversy in the different treatments to treat respiratory distress in premature infants. The data finds that inhaled nitric oxide (iNO) is one of the main treatments for respiratory distress and has had a lot of controversy over the years. Most of the research points to the usefulness of iNO in different doses, although it is controversial as to the right dose amount. There are also a few other treatment possibilities that still need further research. iNO is useful as a treatment, and to hold as a temporary treatment before other treatments can be administered. However, it still has different risks involved especially when dealing with infants.
